The FDA has approved SenoClaire, GE’s breast tomosynthesis device that was developed in collaboration with Massachusetts General Hospital.

Earlier this year, the Swiss Medical Board fanned the flames of the screening mammography debate when it argued that new systemic mammography screening programs should not be introduced and that existing programs should be halted.

Despite the Swiss Medical Board’s recommendation to move away from systematic mammography screening earlier this year, there is not enough evidence to completely abolish such screening programs, according to a pair of Swiss physicians who published an editorial online Aug. 25 in JAMA Internal Medicine.

The ASRT Foundation and Siemens Healthcare USA are excited to announce the recipients of the 2014 Siemens Clinical Advancement Scholarship.

Toshiba is making it possible for clinicians to use ultrasound to see the smallest vessels in and around areas like tumors and lymph nodes, giving them a new way to diagnose disease faster and non-invasively.

Since the U.S. Preventive Services Task Force released mammography recommendations in 2009 that did not include routine screening for women 75 and older, there has been much debate over the benefits of screening in older women. One of the main sticking points for those reluctant to recommend screening in this population is a lack of evidence.

Viztek, the leading provider of complete digital software and hardware diagnostic imaging solutions, will showcase its new Ultra DR software at the upcoming Association for Medical Imaging Management (AHRA) annual meeting in Washington, D.C., August 10 – 13.

For women age 75 and older, breast cancers detected by mammography were diagnosed at an earlier stage, thus reducing the rate of advanced cancers, according to a study published online August 5 in Radiology.